Vulnerability · Published Apr 28, 2026 · Assigned by INCIBE

CVE-2026-5781Multiple vulnerabilities in MphRx's Minerva

High 8.5

In plain English

A high-severity security flaw in Minerva from MphRx. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.2% (higher than 14% of all known vulnerabilities).

Severity (CVSS 4.0)8.5High

Exploit odds (30 days)0.2%top 85.9% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their privileges by sending an HTTP request with a manipulated 'identifier' field. Successful exploitation of this vulnerability could allow an authenticated user to obtain administrator privileges. It is not possible to escalate privileges through the graphical user interface.

Affected products (as reported)

Vendor	Product	Versions
MphRx	Minerva	3.6.0

Weakness: CWE-285 · Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:H/SI:H/SA:H

References

https://www.incibe.es/en/incibe-cert/notices/aviso/multiple-vulnerabilities-mphrxs-minerva